Merck/Schering Vytorin Name, Packaging Concern ISMP
This article was originally published in The Pink Sheet Daily
Executive Summary
The Institute for Safe Medication Practices says similarities in the name and packaging of Vytorin and Vicodin could result in medication errors. ISMP is encouraging a label change for Vytorin.
You may also be interested in...
Reminyl, Amaryl Name Confusion Concerns ISMP
Confusion between the antidiabetic Amaryl and the Alzheimer’s medication Reminyl has resulted in medication errors, the Institute for Safe Medication Practices says. ISMP is working with FDA, Aventis and Janssen to develop a solution.
Reminyl, Amaryl Name Confusion Concerns ISMP
Confusion between the antidiabetic Amaryl and the Alzheimer’s medication Reminyl has resulted in medication errors, the Institute for Safe Medication Practices says. ISMP is working with FDA, Aventis and Janssen to develop a solution.
Merck/Schering's Vytorin Clears FDA
Zetia/Zocor fixed-dose combination will be marketed as a first-line therapy for cholesterol.